While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting amyloid beta due to its role in clogging patients' brains with harmful deposits, a biochemist at the University of California, Santa Cruz, says the peptide has a smaller, overlooked "cousin" that could also be neurotoxic.
Source: https://medicalxpress.com/news/2026-03- ... sease.html
-
Translation